In-centre extended nocturnal haemodialysis: the effects on cardiovascular structure and physical function

ISRCTN ISRCTN16672784
DOI https://doi.org/10.1186/ISRCTN16672784
Secondary identifying numbers UNOLE 0528
Submission date
16/07/2015
Registration date
27/07/2015
Last edited
18/08/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Patients with established renal failure usually undergo haemodialysis for four hours, three times a week, in purpose-built units. This regime tends to place large strain on the heart and body. This strain can result in a number of different symptoms including dizziness, cramps and breathlessness. Haemodialysis itself causes the heart to enlarge and not work properly. In addition to this, most patients on dialysis are known to have very sedentary lifestyles due to the time commitments of their treatment, the nature of renal disease and related illnesses.
Extending dialysis sessions has been shown as one way of reducing the symptoms patients’ experience. This also reduces the strain on the patient’s heart and may improve heart health. One potential way to provide longer sessions is to conduct the haemodialysis sessions overnight and this has the added benefit of freeing up time during the day. Currently the Leicester General Hospital is the only NHS centre in the UK to offer nocturnal haemodialysis sessions, in a hospital setting.
Some previous research by other groups has looked at how receiving dialysis overnight in dialysis units affects the heart. However they have not used the gold standard imaging techniques. Furthermore, no one has yet looked at the effects of nocturnal dialysis on physical function and activity levels. The aim of the study is to compare a thrice weekly in-centre nocturnal regime to the conventional four hour thrice weekly regime.
This exploratory study will use cardiac magnetic resonance imaging (the gold standard technique) to look at how nocturnal dialysis affects the heart. Additionally, we will use simple, validated methods to assess physical function and activity levels. We will collect data on body composition, nutrition, blood biochemistry and markers of inflammation, to look at associations between these results as well as with physical function and activity levels. We will also collect information on quality of life, sleep quality and symptom burden. All the outcomes collected will provide us with high quality or new information that will help in the design of larger studies in the future.

Who can participate?
Adult patients on haemodialysis for more than three months.

What does the study involve?
There are two groups of participants: the intervention group and the control group.
In the intervention group, participants interested in extended hours dialysis in a dialysis unit overnight will switch from conventional daytime treatment to extended treatment overnight.
The control group will be made of participants on conventional day time treatment, who are matched to intervention patients and do not want to undergo extended treatment overnight.

What are the possible benefits and risks of participating?
Patients who receive extended treatment times in the overnight haemodialysis programme may expect to see improvements in their physical and psychological health. There are no other anticipated benefits to taking part in the research.

Where is the study run from?
Leicester General Hospital (UK)

When is the study starting and how long is it expected to run for?
September 2014 to July 2016

Who is funding the study?
Van Geest Heart and Cardiovascular Research Fund, Leicester (UK)

Who is the main contact?
Mr Darren Churchward
dc262@le.ac.uk

Contact information

Mr Darren Churchward
Public

Unversity of Leicester Academic Unit
Leicester General Hospital
Gwendolen Road
Leicester
LE5 4PW
United Kingdom

ORCiD logoORCID ID 0000-0003-4674-186X
Phone +44 (0)116 258 4346
Email dc262@le.ac.uk
Dr James Burton
Scientific

University of Leicester Academic Unit
Leicester General Hospital
Gwendolen Road
Leicester
LE5 4PW
United Kingdom

ORCiD logoORCID ID 0000-0003-1176-7592
Phone +44 (0)116 258 4346
Email jb343@le.ac.uk

Study information

Study designNon-randomized controlled feasibility trial
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleMaintenance In-centre nocturnal haemoDialysis: a feasibility study iNvestIGating the effects on cardiac structure and pHysical funcTion in comparison to conventional treatment
Study acronymMIDNIGHT
Study objectives1. Cardiac structure and function, as measured by CMR and NICOM, will improve in haemodialysis patients who switch from a conventional four hour thrice weekly regime to a thrice weekly in-centre nocturnal regime compared to patients who remain on conventional four hour thrice weekly dialysis.
2. Physical function, as measured by the short physical performance battery and sit-to-stand 60, will improve in haemodialysis patients who switch from a conventional four hour thrice weekly regime to a thrice weekly in-centre nocturnal regime compared to patients who remain on conventional four hour thrice weekly dialysis.
3. The time spent physically active, as measured by accelerometry, will improve in haemodialysis patients who switch from a conventional four hour thrice weekly regime to a thrice weekly in-centre nocturnal regime compared to patients who remain on conventional four hour thrice weekly dialysis.
4. Quality of life, as measured by validated questionnaires will improve in haemodialysis patients who switch from a conventional four hour thrice weekly regime to a thrice weekly in-centre nocturnal regime compared to patients who remain on conventional four hour thrice weekly dialysis.
5. Body composition and nutritional status, as measured by bioelectrical impedance analysis and diet recall, will improve in haemodialysis patients who switch from a conventional four hour thrice weekly regime to a thrice weekly in-centre nocturnal regime compared to patients who remain on conventional four hour thrice weekly dialysis.
6. Inflammatory and biochemical markers including, IL-6, IL-10, CRP, phosphate, calcium, and other markers measured monthly, will improve in haemodialysis patients who switch from a conventional four hour thrice weekly regime to a thrice weekly in-centre nocturnal regime compared to patients who remain on conventional four hour thrice weekly dialysis.
7. Dialysis efficacy will improve in haemodialysis patients who switch from a conventional four hour thrice weekly regime to a thrice weekly in-centre nocturnal regime compared to patients who remain on conventional four hour thrice weekly dialysis.
Ethics approval(s)NRES Committee East Midlands- Northampton, 09/07/2015, REC ref: 15/EM/0268
Health condition(s) or problem(s) studiedTopic: Renal disorders; Subtopic: Renal disorders; Disease: All Renal disorders
InterventionIntervention arm: Patients interested in extended hours dialysis in a dialysis unit overnight and consenting to participation in the trial will switch from conventional daytime treatment

Control arm: Patients on conventional day time treatment, who are matched to intervention patients and do not want to undergo extended treatment overnight, will be recruited.
Intervention typeOther
Primary outcome measureAs this is a feasibility study designed to inform future trial development, no single primary outcome will be selected. All outcomes collected are listed below:
1. Left ventricular mass in grams (using cardiac MR)
2. Cardiac output and other haemodynamic variables measured using the noninvasive
cardiac output monitor (NICOM)
3. Physical performance, specifically gait speed, balance, muscular power and muscular endurance, as assessed by the short physical performance battery and the sit-to-stand 60 tests.
4. Habitual activity levels as assessed by accelerometery
5. Quality of life and perceived physical function assessed using short form 12 questionnaire, palliative outcome scale-symptoms renal questionnaire, Pittsburgh sleep quality index questionnaire, functional assessment of chronic illness treatment fatigue questionnaire, Leicester dialysis patient physical activity questionnaire.
6. Diet quality assessed by either dietary recall interview or food diary
7. Markers of malnutrition, inflammation, cardiovascular dysfunction a and cardiovascular risk assessed by analysis of blood sample
8. Body composition (including lean tissue, fat tissue, fluid overload, body cell mass) assessed by bioimpedance spectroscopy (using body composition monitor)
Secondary outcome measuresPlease see Primary outcome measures section.
Overall study start date01/09/2014
Completion date31/07/2016

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants24
Key inclusion criteria1. Be a prevalent haemodialysis patient for more than three months
2. Age 18 years or older
3. Able and willing to give informed consent
Key exclusion criteria1. Unable to undergo CMR scanning (metal implants / prostheses, claustrophobia etc.)
2. Age <18 years
3. Unable or unwilling to give informed consent
Date of first enrolment20/07/2015
Date of final enrolment01/04/2016

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Leicester
Department of Infection, Immunity and Inflammation
Maurice Shock Medical Sciences Building
University Road
Leicester
LE1 9HN
United Kingdom

Sponsor information

University of Leicester
University/education

University Road
Leicester
LE1 7RH
England
United Kingdom

ROR logo "ROR" https://ror.org/04h699437

Funders

Funder type

Charity

Van Geest Heart and Cardiovascular Research Fund

No information available

Results and Publications

Intention to publish date31/12/2016
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planWe will look to publish data relating to all outcome measures, as well as a methodology paper of the study protocol. Results will be included in a research newsletter that is given to patients to inform them of developments made by our research team and promote the research we are doing.
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article results 08/09/2016 Yes No
HRA research summary 28/06/2023 No No
Results article 31/10/2017 18/08/2023 Yes No

Editorial Notes

18/08/2023: Publication reference and total final enrolment added.
21/02/2018: Publication reference added.
On 11/01/2016 the recruitment end date was changed from 01/12/2015 to 01/04/2016.
The registration was initiated on 16/07/2015 and finalised on 27/07/2015. The recruitment started on 20/07/2015, after initiation of public registration.